All Stories

  1. EatA mediated degradation of intestinal mucus is species-specific and driven by MUC2 structural features
  2. ETEC heat-labile toxin promotes β-catenin stabilization and transcriptional reprogramming to disrupt intestinal epithelial differentiation
  3. Parenteral vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization
  4. Degradation of the intestinal mucus layer by the ETEC protease EatA is species specific determined by the structure of the MUC2 mucin
  5. Parenteral Vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization
  6. Host-derived CEACAM-laden vesicles engage enterotoxigenic Escherichia coli for elimination and toxin neutralization
  7. Structural and biophysical characterization of the secreted, β-helical adhesin EtpA of Enterotoxigenic Escherichia coli
  8. Interactions of pathogenic Escherichia coli with CEACAMs
  9. Spontaneous Bacterial Peritonitis Caused by Bordetella hinzii
  10. Confronting Challenges to Enterotoxigenic Escherichia coli Vaccine Development
  11. Changing the locks on intestinal signaling
  12. Effect of chronic alcohol exposure on gut vitamin B7 uptake: involvement of epigenetic mechanisms and effect of alcohol metabolites
  13. Emerging Themes in the Molecular Pathogenesis of Enterotoxigenic Escherichia coli
  14. Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease
  15. Acute Bacterial Gastroenteritis
  16. Contribution of Noncanonical Antigens to Virulence and Adaptive Immunity in Human Infection with Enterotoxigenic E. coli
  17. The Intriguing Interaction of Escherichia coli with the Host Environment and Innovative Strategies To Interfere with Colonization: a Summary of the 2019 E. coli and the Mucosal Immune System Meeting
  18. CEACAMs serve as toxin-stimulated receptors for enterotoxigenic Escherichia coli
  19. Phosphodiesterase 5 (PDE5) restricts intracellular cGMP accumulation during enterotoxigenic Escherichia coli infection
  20. Mechanical Stimuli Affect Escherichia coli Heat-Stable Enterotoxin-Cyclic GMP Signaling in a Human Enteroid Intestine-Chip Model
  21. Comparative genomic analysis and molecular examination of the diversity of enterotoxigenic Escherichia coli isolates from Chile
  22. Mechanical Stimuli Affect E. Coli Heat Stable Enterotoxin (ST)-Cyclic GMP Signaling in a Human Enteroid Intestine-Chip Diarrhea Model
  23. Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection
  24. How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions
  25. Enterotoxigenic Escherichia coli–blood group A interactions intensify diarrheal severity
  26. Enterotoxigenic Escherichia coli Infections
  27. Molecular Determinants of Enterotoxigenic Escherichia coli Heat-Stable Toxin Secretion and Delivery
  28. Enterotoxigenic Escherichia coli–blood group A interactions intensify diarrheal severity
  29. Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development
  30. Molecular determinants of enterotoxigenic Escherichia coli heat-stable toxin secretion and delivery
  31. A Role for Salivary Peptides in the Innate Defense Against Enterotoxigenic Escherichia coli
  32. Characterization of enterotoxigenic Escherichia coli strains isolated from the massive multi-pathogen gastroenteritis outbreak in the Antofagasta region following the Chilean earthquake, 2010
  33. Comparative genomics and transcriptomics of Escherichia coli isolates carrying virulence factors of both enteropathogenic and enterotoxigenic E. coli
  34. Insights into enterotoxigenic Escherichia coli diversity in Bangladesh utilizing genomic epidemiology
  35. Providing Structure to Enterotoxigenic Escherichia coli Vaccine Development
  36. Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions
  37. Dynamic Interactions of a Conserved Enterotoxigenic Escherichia coli Adhesin with Intestinal Mucins Govern Epithelium Engagement and Toxin Delivery
  38. Blood Group O–Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera
  39. Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin
  40. Overcoming Enterotoxigenic Escherichia coli Pathogen Diversity: Translational Molecular Approaches to Inform Vaccine Design
  41. Examination of the Enterotoxigenic Escherichia coli Population Structure during Human Infection
  42. Conservation and Immunogenicity of Novel Antigens in Diverse Isolates of Enterotoxigenic Escherichia coli
  43. Contribution of the Highly Conserved EaeH Surface Protein to Enterotoxigenic Escherichia coli Pathogenesis
  44. Designing Vaccines to Neutralize Effective Toxin Delivery by Enterotoxigenic Escherichia coli
  45. Novel antigens for enterotoxigenicEscherichia colivaccines
  46. Enterotoxigenic Escherichia coli Secretes a Highly Conserved Mucin-Degrading Metalloprotease To Effectively Engage Intestinal Epithelial Cells
  47. EatA, an Immunogenic Protective Antigen of Enterotoxigenic Escherichia coli, Degrades Intestinal Mucin
  48. EnterotoxigenicEscherichia coli
  49. Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans
  50. Enterotoxigenic Escherichia coli
  51. Transcriptional Modulation of Enterotoxigenic Escherichia coli Virulence Genes in Response to Epithelial Cell Interactions
  52. Cooperative Role of Antibodies against Heat-Labile Toxin and the EtpA Adhesin in Preventing Toxin Delivery and Intestinal Colonization by Enterotoxigenic Escherichia coli
  53. Directed Evaluation of Enterotoxigenic Escherichia coli Autotransporter Proteins as Putative Vaccine Candidates
  54. Outer Membrane Vesicles Induce Immune Responses to Virulence Proteins and Protect against Colonization by Enterotoxigenic Escherichia coli
  55. Adhesin Degradation Accelerates Delivery of Heat-labile Toxin by EnterotoxigenicEscherichia coli
  56. Infectious Agents of Food- and Water-Borne Illnesses
  57. Enterotoxigenic Escherichia coli Elicits Immune Responses to Multiple Surface Proteins
  58. Lingual Leishmaniasis Complicating Visceral Disease
  59. Molecular mechanisms of enterotoxigenic Escherichia coli infection
  60. Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model
  61. Purification of recombinant high molecular weight two-partner secretion proteins from Escherichia coli
  62. Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells
  63. Heat-Labile Enterotoxin Promotes Escherichia coli Adherence to Intestinal Epithelial Cells
  64. The EtpA Exoprotein of Enterotoxigenic Escherichia coli Promotes Intestinal Colonization and Is a Protective Antigen in an Experimental Model of Murine Infection
  65. Directed delivery of heat-labile enterotoxin by enterotoxigenic Escherichia coli
  66. Identification of a Two-Partner Secretion Locus of Enterotoxigenic Escherichia coli
  67. Importance of Heat-Labile Enterotoxin in Colonization of the Adult Mouse Small Intestine by Human Enterotoxigenic Escherichia coli Strains
  68. Identification and Molecular Characterization of EatA, an Autotransporter Protein of Enterotoxigenic Escherichia coli
  69. Interaction of an Outer Membrane Protein of Enterotoxigenic Escherichia coli with Cell Surface Heparan Sulfate Proteoglycans
  70. Breaching the mucosal barrier by stealth: an emerging pathogenic mechanism for enteroadherent bacterial pathogens
  71. Identification of a Gene within a Pathogenicity Island of Enterotoxigenic Escherichia coli H10407 Required for Maximal Secretion of the Heat-Labile Enterotoxin
  72. Incidental Discovery of Emphysematous Cystitis
  73. Cryptococcal Skull Infection